+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Therapy Technologies Market Size, Share & Trends Analysis Report by Product (Raw Materials, Instruments), Workflow (Separation, Expansion), Cell Type (T-Cells, Stem Cells), End Use, and Region with Growth Forecasts, 2025-2030- Product Image
Cell Therapy Technologies Market Size, Share & Trends Analysis Report by Product (Raw Materials, Instruments), Workflow (Separation, Expansion), Cell Type (T-Cells, Stem Cells), End Use, and Region with Growth Forecasts, 2025-2030- Product Image
New

Cell Therapy Technologies Market Size, Share & Trends Analysis Report by Product (Raw Materials, Instruments), Workflow (Separation, Expansion), Cell Type (T-Cells, Stem Cells), End Use, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 120 Pages
  • February 2025
  • Region: Global
  • Grand View Research
  • ID: 6055949
Description Jump to:
The Cell Therapy Technologies Market was valued at USD 6.54 billion in 2024, and is projected to reach USD 17.46 billion by 2030, rising at a CAGR of 17.84%. The market is driven by rising demand for advanced treatments, especially in cancer, autoimmune diseases, and regenerative medicine. Automation, bioprocessing innovations, increasing R&D investments, and supportive regulations fuel growth. Companies are expanding manufacturing capabilities and partnerships to improve efficiency, scalability, and product development, which is further anticipated to fuel the demand for cell therapy technologies.

The COVID-19 pandemic accelerated the cell therapy technologies market by increasing R&D investments, clinical trials, and demand for advanced therapies. It highlighted the need for automation, efficient manufacturing, and scalable production in regenerative medicine and immune-based treatments, driving innovation and industry growth. These factors have impelled the growth of the market and are anticipated to propel exponentially over the forecast period.

The growing adoption of advanced cell therapies, including CAR-T, TCR-T, and stem cell treatments, is expected to drive further demand for cell therapy technologies. Innovations in gene editing, automation, and bioprocessing are enhancing efficiency, scalability, and production quality. As more personalized and regenerative treatments gain approval, the need for specialized equipment, raw materials, and manufacturing solutions will continue to rise. These factors are thus projected to impel the market's growth over the forecast period.

The high cost of cell therapy technologies could slow market growth in the coming years. Expensive raw materials, complex manufacturing, and strict regulations make production costly. Companies also need specialized equipment, skilled workers, and advanced technology, adding to expenses. Limited insurance coverage and pricing challenges may further restrict adoption. Reducing costs through better processes, automation, and scaling up production will be key for future growth.

Cell Therapy Technologies Market Report Highlights

  • Based on products, the consumables segment held the largest market share of 42.70% in 2024 due to their wide use in cell culture, expansion, and processing. The recurring demand for reagents, growth factors, and media in research, clinical trials, and commercial production has driven significant growth. On the other hand, software is expected to grow at the fastest CAGR over the forecast period
  • Based on workflow, the separation segment is expected to lead the market and grow at the fastest CAGR (2025-2030) due to increasing demand for automated, efficient cell isolation techniques in therapy development and manufacturing. The expansion segment is expected to grow significantly over the forecast period
  • Based on cell-type, the T-cells segment is expected to dominate the market and grow at the fastest CAGR (2025-2030) due to increasing adoption of CAR-T and TCR-T therapies for cancer, autoimmune diseases, and infectious diseases, along with advancements in gene editing and cell expansion technologies. The stem cells segment is expected to grow significantly over the forecast period.
  • Based on end use, the biopharmaceutical & pharmaceutical companies segment dominated the market in 2024 due to increasing investments in cell therapy R&D, growing demand for advanced treatments, and expanding commercial manufacturing capabilities for cancer, autoimmune, and regenerative therapies. On the other hand, CMOs & CROs are expected to grow at the fastest CAGR over the forecast period

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. Workflow
1.2.3. Cell Type
1.2.4. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Cell Therapy Technologies Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Advancements in Cell-Based Therapies
3.2.1.2. Increased Funding and Investment
3.2.2. Market restraint analysis
3.2.2.1. High Costs and Manufacturing Challenges
3.3. Cell Therapy Technologies Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Cell Therapy Technologies Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Cell Therapy Technologies Market Product Movement Analysis
4.3. Global Cell Therapy Technologies Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Raw Materials
4.4.1. Raw materials market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Media
4.4.2.1. Media market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Sera
4.4.3.1. Sera market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Cell Culture Supplements
4.4.4.1. Cell Culture Supplements market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Antibodies
4.4.5.1. Antibodies market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Reagents & Buffers
4.4.6.1. Reagents & buffers market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7. Others
4.4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Instruments
4.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Cell Therapy Processing Systems
4.5.2.1. Cell therapy processing systems market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Cell Culture Systems
4.5.3.1. Cell culture systems market estimates and forecasts 2018 to 2030 (USD Million)
4.5.4. Cell Sorting & Separation Systems
4.5.4.1. Cell sorting & separation systems market estimates and forecasts 2018 to 2030 (USD Million)
4.5.5. Other Instruments
4.5.5.1. Other instruments market estimates and forecasts 2018 to 2030 (USD Million)
4.5.6. Software
4.5.6.1. Software market estimates and forecasts 2018 to 2030 (USD Million)
4.5.7. Consumables & Accessories
4.5.7.1. Consumables & accessories market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Cell Therapy Technologies Market: Workflow Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Cell Therapy Technologies Market Dosage Workflow Movement Analysis
5.3. Global Cell Therapy Technologies Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
5.4. Separation
5.4.1. Separation market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Expansion
5.5.1. Expansion market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Apheresis
5.6.1. Apheresis market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Fill- Finish
5.7.1. Fill- finish market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Cryopreservation
5.8.1. Cryopreservation market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Cell Therapy Technologies Market: Cell Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Cell Therapy Technologies Market Cell Type Movement Analysis
6.3. Global Cell Therapy Technologies Market Size & Trend Analysis, by Cell Type, 2018 to 2030 (USD Million)
6.4. T-cells
6.4.1. T-cells market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Stem Cells
6.5.1. Stem cells market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Other Cells
6.6.1. Other cells market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Cell Therapy Technologies Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Cell Therapy Technologies Market End Use Movement Analysis
7.3. Global Cell Therapy Technologies Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Biopharmaceutical & Biotechnology Companies
7.4.1. Biopharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
7.5. CMOs & CROs
7.5.1. CMOs & CROs market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Others
7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Cell Therapy Technologies Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework
8.4.2.3. Competitive scenario
8.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework
8.4.3.3. Competitive scenario
8.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework
8.4.4.3. Competitive scenario
8.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Europe
8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. France
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Competitive scenario
8.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework
8.5.5.3. Competitive scenario
8.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework
8.5.6.3. Competitive scenario
8.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.5.7. Norway
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework
8.5.7.3. Competitive scenario
8.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.5.8. Sweden
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework
8.5.8.3. Competitive scenario
8.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.5.9. Denmark
8.5.9.1. Key country dynamics
8.5.9.2. Regulatory framework
8.5.9.3. Competitive scenario
8.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. China
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. India
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Australia
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. South Korea
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework
8.6.7.3. Competitive scenario
8.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. Argentina
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework
8.7.3.3. Competitive scenario
8.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.8. MEA
8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive scenario
8.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Competitive scenario
8.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key country dynamics
8.8.5.2. Regulatory framework
8.8.5.3. Competitive scenario
8.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Danaher Corporation
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Merck KGaA
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Thermo Fisher Scientific Inc.
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Lonza Group
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Sartorius AG
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Promega
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. BD
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Miltenyi Biotec
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. CellPort Software
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Shimadzu
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global cell therapy technologies market, by region, 2018-2030 (USD Million)
Table 3 Global cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 4 Global cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 5 Global cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 6 Global cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 7 North America cell therapy technologies market, by country, 2018-2030 (USD Million)
Table 8 North America cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 9 North America cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 10 North America cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 11 North America cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 12 U.S. cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 13 U.S. cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 14 U.S. cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 15 U.S. cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 16 Canada cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 17 Canada cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 18 Canada cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 19 Canada cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 20 Mexico cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 21 Mexico cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 22 Mexico cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 23 Mexico cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 24 Europe cell therapy technologies market, by country, 2018-2030 (USD Million)
Table 25 Europe cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 26 Europe cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 27 Europe cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 28 Europe cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 29 Germany cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 30 Germany cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 31 Germany cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 32 Germany cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 33 UK cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 34 UK cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 35 UK cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 36 UK cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 37 France cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 38 France cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 39 France cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 40 France cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 41 Italy cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 42 Italy cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 43 Italy cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 44 Italy cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 45 Spain cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 46 Spain cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 47 Spain cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 48 Spain cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 49 Denmark cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 50 Denmark cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 51 Denmark cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 52 Denmark cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 53 Sweden cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 54 Sweden cell therapy technologies market, by workflow, 2018-2030 (USD Million
Table 55 Sweden cell therapy technologies market, by cell type, 2018-2030 (USD Million
Table 56 Sweden cell therapy technologies market, by end use, 2018-2030 (USD Million
Table 57 Norway cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 58 Norway cell therapy technologies market, by workflow, 2018-2030 (USD Million
Table 59 Norway cell therapy technologies market, by cell type, 2018-2030 (USD Million
Table 60 Norway cell therapy technologies market, by end use, 2018-2030 (USD Million
Table 61 Asia Pacific cell therapy technologies market, by country, 2018-2030 (USD Million)
Table 62 Asia Pacific cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 63 Asia Pacific cell therapy technologies market, by workflow, 2018-2030 (USD Million
Table 64 Asia Pacific cell therapy technologies market, by cell type, 2018-2030 (USD Million
Table 65 Asia Pacific cell therapy technologies market, by end use, 2018-2030 (USD Million
Table 66 China cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 67 China cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 68 China cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 69 China cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 70 Japan cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 71 Japan cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 72 Japan cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 73 Japan cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 74 India cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 75 India cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 76 India cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 77 India cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 78 South Korea cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 79 South Korea cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 80 South Korea cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 81 South Korea cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 82 Australia cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 83 Australia cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 84 Australia cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 85 Australia cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 86 Thailand cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 87 Thailand cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 88 Thailand cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 89 Thailand cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 90 Latin America cell therapy technologies market, by country, 2018-2030 (USD Million)
Table 91 Latin America cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 92 Latin America cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 93 Latin America cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 94 Latin America cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 95 Brazil cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 96 Brazil cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 97 Brazil cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 98 Brazil cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 99 Argentina cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 100 Argentina cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 101 Argentina cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 102 Argentina cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 103 MEA cell therapy technologies market, by country, 2018-2030 (USD Million)
Table 104 MEA cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 105 MEA cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 106 MEA cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 107 MEA cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 108 South Africa cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 109 South Africa cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 110 South Africa cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 111 South Africa cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 112 Saudi Arabia cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 113 Saudi Arabia cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 114 Saudi Arabia cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 115 Saudi Arabia cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 116 UAE cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 117 UAE cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 118 UAE cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 119 UAE cell therapy technologies market, by end use, 2018-2030 (USD Million)
Table 120 Kuwait cell therapy technologies market, by product, 2018-2030 (USD Million)
Table 121 Kuwait cell therapy technologies market, by workflow, 2018-2030 (USD Million)
Table 122 Kuwait cell therapy technologies market, by cell type, 2018-2030 (USD Million)
Table 123 Kuwait cell therapy technologies market, by end use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Market formulation & validation
Figure 4 Cell therapy technologies market: Market outlook
Figure 5 Cell therapy technologies market: Segment outlook
Figure 6 Cell therapy technologies market: Competitive landscape outlook
Figure 7 Parent market outlook
Figure 8 Cell therapy technologies market driver impact
Figure 9 Cell therapy technologies market restraint impact
Figure 10 Cell therapy technologies market: Product outlook and key takeaways
Figure 11 Cell therapy technologies market: Product movement analysis
Figure 12 Raw materials market estimates and forecast, 2018-2030 (USD Million)
Figure 13 Media market estimates and forecast, 2018-2030 (USD Million)
Figure 14 Sera market estimates and forecast, 2018-2030 (USD Million)
Figure 15 Cell culture supplements market estimates and forecast, 2018-2030 (USD Million)
Figure 16 Antibodies market estimates and forecast, 2018-2030 (USD Million)
Figure 17 Reagents & buffers market estimates and forecast, 2018-2030 (USD Million)
Figure 18 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 19 Instruments market estimates and forecast, 2018-2030 (USD Million)
Figure 20 Cell therapy processing systems market estimates and forecast, 2018-2030 (USD Million)
Figure 21 Cell culture systems market estimates and forecast, 2018-2030 (USD Million)
Figure 22 Cell sorting & separation systems market estimates and forecast, 2018-2030 (USD Million)
Figure 23 Other instruments market estimates and forecast, 2018-2030 (USD Million)
Figure 24 Software market estimates and forecast, 2018-2030 (USD Million)
Figure 25 Consumables & accessories market estimates and forecast, 2018-2030 (USD Million)
Figure 26 Cell therapy technologies market: Workflow outlook and key takeaways
Figure 27 Cell therapy technologies market: Workflow movement analysis
Figure 28 Separation market estimates and forecast, 2018-2030 (USD Million)
Figure 29 Expansion market estimates and forecast, 2018-2030 (USD Million
Figure 30 Apheresis market estimates and forecast, 2018-2030 (USD Million)
Figure 31 Fill- finish market estimates and forecast, 2018-2030 (USD Million)
Figure 32 Cryopreservation market estimates and forecast, 2018-2030 (USD Million)
Figure 33 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 34 Cell therapy technologies market: Cell type outlook and key takeaways
Figure 35 Cell therapy technologies market: Cell type movement analysis
Figure 36 T-cells market estimates and forecast, 2018-2030 (USD Million)
Figure 37 Stem cells market estimates and forecast, 2018-2030 (USD Million
Figure 38 Other cells market estimates and forecast, 2018-2030 (USD Million)
Figure 39 Cell therapy technologies market: End use outlook and key takeaways
Figure 40 Cell therapy technologies market: End use movement analysis
Figure 41 Biopharmaceutical & biotechnology companies market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 CMOs & CROs market estimates and forecasts,2018-2030 (USD Million)
Figure 43 Others market estimates and forecasts,2018-2030 (USD Million)
Figure 44 Global cell therapy technologies market: Regional outlook and key takeaways
Figure 45 Global cell therapy technologies market: Regional movement analysis
Figure 46 North America cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 U.S. cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 Canada cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 Mexico cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Europe cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 UK cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 Germany cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 53 France cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Italy cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 55 Spain cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 56 Denmark cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 57 Sweden cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 58 Norway cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 59 Asia Pacific cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 60 China cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 61 Japan cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 62 India cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 63 Thailand cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 64 South Korea cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 65 Australia cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 66 Latin America cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 67 Brazil cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 68 Argentina cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 69 Middle East and Africa cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 70 South Africa cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 71 Saudi Arabia cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 72 UAE cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)
Figure 73 Kuwait cell therapy technologies market estimates and forecasts, 2018-2030 (USD Million)

Companies Mentioned

The major companies profiled in this Cell Therapy Technologies market report include:
  • Danaher Corporation
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Lonza Group
  • Sartorius AG
  • Promega
  • BD
  • Miltenyi Biotec
  • CellPort Software
  • Shimadzu

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedFebruary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 6.54 Billion
Forecasted Market Value ( USD ) by 2030 $ 17.46 Billion
Compound Annual Growth Rate17.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation), By Type (Stem Cell Therapy), By Scale (Commercial Scale), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation), By Type (Stem Cell Therapy), By Scale (Commercial Scale), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 130 Pages
  • Global
From
Cell And Gene Therapy Manufacturing Market Size, Share & Trends Analysis Report By Therapy Type, By Scale (R&D), By Mode, By Workflow (Vector Production, Cell Banking), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Cell And Gene Therapy Manufacturing Market Size, Share & Trends Analysis Report By Therapy Type, By Scale (R&D), By Mode, By Workflow (Vector Production, Cell Banking), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 217 Pages
  • Global
From
U.S. Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation, Expansion), By Type (Stem Cell Therapy, Non-stem Cell Therapy), By Scale, And Segment Forecasts, 2025 - 2030 - Product Image

U.S. Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation, Expansion), By Type (Stem Cell Therapy, Non-stem Cell Therapy), By Scale, And Segment Forecasts, 2025 - 2030

  • Report
  • 75 Pages
  • United States
From
Automated & Closed Cell Therapy Processing Systems Market by Workflow, Type, Scale - Global Forecast 2025-2030 - Product Image

Automated & Closed Cell Therapy Processing Systems Market by Workflow, Type, Scale - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
U.S. Cell and Gene Therapy Clinical Trial Services Market Size, Share & Trends Analysis Report by Service (Site Identification, Patient Recruitment), Phase (Phase I, Phase II), Therapeutic Areas, Therapy Type, and Segment Forecasts, 2024-2030 - Product Image

U.S. Cell and Gene Therapy Clinical Trial Services Market Size, Share & Trends Analysis Report by Service (Site Identification, Patient Recruitment), Phase (Phase I, Phase II), Therapeutic Areas, Therapy Type, and Segment Forecasts, 2024-2030

  • Report
  • 183 Pages
  • United States
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.